These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 19498198)

  • 61. Transcranial Doppler as a Screening Tool for High-Risk Patent Foramen Ovale in Cryptogenic Stroke.
    Park S; Oh JK; Song JK; Kwon B; Kim BJ; Kim JS; Kang DW; Chang JY; Lee JS; Kwon SU
    J Neuroimaging; 2021 Jan; 31(1):165-170. PubMed ID: 32896963
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Frequency of Patent Foramen Ovale and Migraine in Patients With Cryptogenic Stroke.
    West BH; Noureddin N; Mamzhi Y; Low CG; Coluzzi AC; Shih EJ; Gevorgyan Fleming R; Saver JL; Liebeskind DS; Charles A; Tobis JM
    Stroke; 2018 May; 49(5):1123-1128. PubMed ID: 29636424
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Recurrent stroke in patients with patent foramen ovale: An observational prospective study of percutaneous closure of PFO versus non-closure.
    Mirzada N; Ladenvall P; Hansson PO; Eriksson P; Dellborg M
    Int J Cardiol; 2015 Sep; 195():293-9. PubMed ID: 26056962
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antiphospholipid antibodies are common in patients referred for percutaneous patent foramen ovale closure.
    Dodge SM; Hassell K; Anderson CA; Keller J; Groves B; Carroll JD
    Catheter Cardiovasc Interv; 2004 Jan; 61(1):123-7. PubMed ID: 14696171
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism.
    Wahl A; Jüni P; Mono ML; Kalesan B; Praz F; Geister L; Räber L; Nedeltchev K; Mattle HP; Windecker S; Meier B
    Circulation; 2012 Feb; 125(6):803-12. PubMed ID: 22238228
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm.
    Mas JL; Zuber M
    Am Heart J; 1995 Nov; 130(5):1083-8. PubMed ID: 7484740
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Patent Foramen Ovale and Risk of Recurrence in Stroke of Determined Etiology.
    Baik M; Shim CY; Gwak SY; Kim YD; Nam HS; Lee HS; Nam CM; Heo JH
    Ann Neurol; 2022 Oct; 92(4):596-606. PubMed ID: 35753038
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A meta-analysis of transcatheter closure of patent foramen ovale versus medical therapy for prevention of recurrent thromboembolic events in patients with cryptogenic cerebrovascular events.
    Pineda AM; Nascimento FO; Yang SC; Kirtane AJ; Sommer RJ; Beohar N
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):968-75. PubMed ID: 23832613
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder.
    Kutty S; Brown K; Asnes JD; Rhodes JF; Latson LA
    Am J Cardiol; 2008 May; 101(10):1487-92. PubMed ID: 18471463
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Embolic implications of combined risk factors in patients with patent foramen ovale (the CARPE criteria): consideration for primary prevention closure?
    Rigatelli G; Dell'Avvocata F; Giordan M; Braggion G; Aggio S; Chinaglia M; Roncon L; Cardaioli P; Chen JP
    J Interv Cardiol; 2009 Aug; 22(4):398-403. PubMed ID: 19515082
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Initial experience with the novel patent foramen ovale occlusion device Nit-Occlud® in patients with stroke or transient ischemic attack.
    Steinberg DH; Bertog SC; Momberger J; Franke J; Hofmann I; Renkhoff K; Joy S; Vaskelyte L; Sievert H
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1262-7. PubMed ID: 24948394
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Percutaneous transcatheter closure of high-risk patent foramen ovale in the elderly.
    Takafuji H; Hosokawa S; Ogura R; Hiasa Y
    Heart Vessels; 2019 Oct; 34(10):1657-1662. PubMed ID: 30868214
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Patent foramen ovale and cryptogenic stroke: from studies to clinical practice: Position paper of the Italian Chapter, International Society Cardiovascular Ultrasound.
    Savino K; Maiello M; Pelliccia F; Ambrosio G; Palmiero P
    Int J Clin Pract; 2016 Aug; 70(8):641-8. PubMed ID: 27384340
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Identification of High-Risk Patent Foramen Ovale Associated With Cryptogenic Stroke: Development of a Scoring System.
    Nakayama R; Takaya Y; Akagi T; Watanabe N; Ikeda M; Nakagawa K; Toh N; Ito H
    J Am Soc Echocardiogr; 2019 Jul; 32(7):811-816. PubMed ID: 31130417
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke.
    Mas JL; Derumeaux G; Guillon B; Massardier E; Hosseini H; Mechtouff L; Arquizan C; Béjot Y; Vuillier F; Detante O; Guidoux C; Canaple S; Vaduva C; Dequatre-Ponchelle N; Sibon I; Garnier P; Ferrier A; Timsit S; Robinet-Borgomano E; Sablot D; Lacour JC; Zuber M; Favrole P; Pinel JF; Apoil M; Reiner P; Lefebvre C; Guérin P; Piot C; Rossi R; Dubois-Randé JL; Eicher JC; Meneveau N; Lusson JR; Bertrand B; Schleich JM; Godart F; Thambo JB; Leborgne L; Michel P; Pierard L; Turc G; Barthelet M; Charles-Nelson A; Weimar C; Moulin T; Juliard JM; Chatellier G;
    N Engl J Med; 2017 Sep; 377(11):1011-1021. PubMed ID: 28902593
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Atherosclerotic burden findings in young cryptogenic stroke patients with and without a patent foramen ovale.
    Rodés-Cabau J; Noël M; Marrero A; Rivest D; Mackey A; Houde C; Bédard E; Larose E; Verreault S; Peticlerc M; Pibarot P; Bogaty P; Bertrand OF
    Stroke; 2009 Feb; 40(2):419-25. PubMed ID: 19095992
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Characteristics and prognosis of patients with cryptogenic stroke and suggestive of patent foramen ovale.
    Choi J; Kang MK; Jun JS; Shin DG; Han D; Choi S; Cho JR; Lee N
    Cardiovasc Ultrasound; 2021 Jun; 19(1):20. PubMed ID: 34090472
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Impact of Patent Foramen Ovale Anatomic Features on Right-to-Left Shunt in Patients with Cryptogenic Stroke.
    Zhu Y; Zhang J; Huang B; Liu Y; Deng Y; Weng Y; Sun R
    Ultrasound Med Biol; 2021 May; 47(5):1289-1298. PubMed ID: 33541750
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Transesophageal echocardiography in patients with cryptogenic cerebral ischemia.
    Knebel F; Masuhr F; von Hausen W; Walde T; Dreger H; Raab V; Yuerek M; Baumann G; Borges AC
    Cardiovasc Ultrasound; 2009 Mar; 7():15. PubMed ID: 19327171
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Contrast transoesophageal echocardiography remains superior to contrast-enhanced cardiac magnetic resonance imaging for the diagnosis of patent foramen ovale.
    Hamilton-Craig C; Sestito A; Natale L; Meduri A; Santangeli P; Infusino F; Pilato F; Di Lazzaro V; Crea F; Lanza GA
    Eur J Echocardiogr; 2011 Mar; 12(3):222-7. PubMed ID: 21193485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.